(Q46724380)

24 December 2017

title

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism (English)

1 reference

24 December 2017

author

Vasilios G. Athyros

7

1 reference

24 December 2017

Dimitri P Mikhailidis

8

object named as

Dimitri P Mikhailidis

1 reference

24 December 2017

Efstathios D Pagourelias

5

object named as

Efstathios D Pagourelias

1 reference

24 December 2017

author name string

Asterios Karagiannis

1

1 reference

24 December 2017

Konstantinos Tziomalos

2

1 reference

24 December 2017

Athanasios Papageorgiou

3

1 reference

24 December 2017

Anna I Kakafika

4

1 reference

24 December 2017

Panagiotis Anagnostis

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

24 December 2017

Expert Opinion on Pharmacotherapy

published in

1 reference

24 December 2017

volume

9

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

509-515

1 reference

24 December 2017

The aldosterone antagonist and facultative diuretic eplerenone: a critical review

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

A review of the medical treatment of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Primary aldosteronism: renaissance of a syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

The 45-year story of the development of an anti-aldosterone more specific than spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

The evolution of aldosterone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

The pharmacological treatment of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Primary aldosteronism: current knowledge and controversies in Conn's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Mineralocorticoid receptors and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Pathophysiological effects of aldosterone in cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Role for adrenal venous sampling in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

Primary aldosteronism: are we diagnosing and operating on too few patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

The treatment of low-renin ("primary") hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.9.4.509

21 January 2018

Identifiers

DOI

10.1517/14656566.9.4.509

1 reference

24 December 2017

1 reference

24 December 2017